Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Current Assets (2016 - 2017)

Bone Biologics has reported Current Assets over the past 3 years, most recently at $795513.0 for Q4 2017.

  • Quarterly Current Assets rose 13.5% to $795513.0 in Q4 2017 from the year-ago period, while the trailing twelve-month figure was $795513.0 through Dec 2017, up 13.5% year-over-year, with the annual reading at $795513.0 for FY2017, 13.5% up from the prior year.
  • Current Assets was $795513.0 for Q4 2017 at Bone Biologics, down from $1.7 million in the prior quarter.
  • Over five years, Current Assets peaked at $4.3 million in Q1 2016 and troughed at $700898.0 in Q4 2016.
  • The 3-year median for Current Assets is $1.5 million (2015), against an average of $1.6 million.
  • The largest YoY upside for Current Assets was 116.36% in 2017 against a maximum downside of 62.79% in 2017.
  • A 3-year view of Current Assets shows it stood at $1.5 million in 2015, then crashed by 54.52% to $700898.0 in 2016, then grew by 13.5% to $795513.0 in 2017.
  • Per Business Quant, the three most recent readings for BBLG's Current Assets are $795513.0 (Q4 2017), $1.7 million (Q3 2017), and $868195.0 (Q2 2017).